Delivery Order SPE2DB20D1100-SPE2DB25FE5N9
- Not listed
- The Defense Logistics Agency awarded a $3,384.40 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of July 31, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,851.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of August 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a routine pharmaceutical procurement through DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $4,061.28 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,030.64 for Cervidil 10 mg vaginal inserts by the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a contract ceiling value of $2,707.52. The delivery order is structured as a firm fixed price contract with a completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,153.20 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with a firm fixed price structure and an ultimate completion date of September 4, 2025. This contract is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The award was made competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,353.76 by the Defense Logistics Agency on September 10, 2025, for the supply of Cervidil 10 mg vaginal inserts. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 11, 2025. This award was made on a competitive basis with no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5N9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with performance completed by September 10, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. The award represents a routine pharmaceutical procurement through the federal medical supply chain to support defense and military healthcare requirements. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent track record of competitive awards and firm fixed-price delivery orders demonstrates its established capability to meet federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/9/25 |